entertainment -WSS

entertainment

author：entertainment 2025-10-01 11:43:50 - browse：9742

A judge ruled that Welsh Carson won't have to face antitrust allegations about its anesthesiology practice. Adobe

Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade Commission, but the private equity firm’s anesthesia company, U.S. Anesthesia Partners, still must face the agency’s antitrust case, a judge ruled last week.

The FTC alleged last year that the anesthesiology network monopolized markets in Texas to drive up prices, but took the unusual step of attaching Welsh Carson as a defendant with USAP. Dismissing Welsh Carson from the case was a victory for the private equity firm and, more broadly, other firms worried that the Biden administration would try to hold them responsible for anything their portfolio companies do.

But the allegations against USAP didn’t disappear, which will keep up scrutiny on companies that have made a push to acquire numerous physician groups.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Microbiome research is starting to find links to chronic diseases

WSS

Why are Kaiser Permanente staff considering a strike?

Lasker Awards 2023: Winners in biomedical research

CDC advisers recommend seasonal use of Pfizer RSV shot

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

How to use technology to prevent future drug shortages

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

knowledge

23andMe had bad news about my health. I wish a person had delivered it

American woman, child freed after being kidnapped in Haiti last month

Continuity nursing helped my family in our darkest PICU moments

A biotech analyst on neuroscience, placebo effect, not over

Affirmative action in medical school literally saved lives

Microbiome research is starting to find links to chronic diseases

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Anavex keeps shifting the goalposts in its clinical trials

Affirmative action in medical school literally saved lives

Second xenotransplant done with gene

hotspot

FDA panel to weigh approval of NurOwn, controversial ALS drug

FDA panel to weigh approval of NurOwn, controversial ALS drug

Thermo Fisher plant for manufacturing gene therapies to expand

Methadone doses haven’t kept up in the age of fentanyl

American woman, child freed after being kidnapped in Haiti last month

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

focus

focus

knowledge

Wikipedia